Harrow Inc

F:3IP

Business Description

Sector

Health Care

Industry

Pharmaceuticals

Headquarters

United States of America US

Employees

373

IPO date

Feb 8, 2013

Harrow Health is an eye-care pharmaceutical company. It makes and sells prescription medicines and related products used by ophthalmologists, eye surgeons, and other eye-care providers, including branded drugs and compounded eye medications. Its products are meant for conditions around the eye and for use in clinics, surgery centers, and pharmacies that serve patients with vision-related needs.

The company earns money mainly by selling these eye-care products and, in some cases, by licensing or commercializing medicines it has developed or acquired. Its customers are mostly doctors, medical practices, surgery centers, and specialty pharmacies that buy products for patient treatment.

What makes Harrow different is its narrow focus on ophthalmology. Instead of trying to serve all of healthcare, it concentrates on a small set of eye-care treatments where product quality, doctor relationships, and specialty distribution matter a lot. That gives it a more specialized role in the drug supply chain than a broad pharmaceutical company.